Universal Health Realty Income Trust
UHT
#7146
Rank
$0.55 B
Marketcap
$39.86
Share price
-1.73%
Change (1 day)
4.87%
Change (1 year)

Universal Health Realty Income Trust - 10-Q quarterly report FY


Text size:
================================================================================


FORM 10-Q

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549
(MARK ONE)
( x ) QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended September 30, 2001

OR

( ) TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from ........ to .........
Commission file number 1-9321

UNIVERSAL HEALTH REALTY INCOME TRUST
------------------------------------

(Exact name of registrant as specified in its charter)

MARYLAND 23-6858580
------------------------------- ------------------
(State or other jurisdiction of (I. R. S. Employer
Incorporation or Organization) Identification No.)


UNIVERSAL CORPORATE CENTER
367 SOUTH GULPH ROAD
KING OF PRUSSIA, PENNSYLVANIA 19406
----------------------------------------------------
(Address of principal executive offices) (Zip Code)

Registrant's telephone number, including area code (610) 265-0688

Indicate by check mark whether the registrant (1) has filed all reports required
to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during
the preceding 12 months (or for such shorter period that the registrant was
required to file such reports), and (2) has been subject to such filing
requirements for the past 90 days. Yes X No _____
-----

Number of common shares of beneficial interest outstanding at October 31, 2001 -
11,623,191


================================================================================

Page 1 of 16
UNIVERSAL HEALTH REALTY INCOME TRUST

I N D E X


PART I. FINANCIAL INFORMATION PAGE NO.

Item 1. Financial Statements

Consolidated Statements of Income
Three and Nine Months Ended - September 30, 2001 and 2000...................3

Consolidated Balance Sheets -- September 30, 2001
and December 31, 2000.......................................................4

Consolidated Statements of Cash Flows
Nine Months Ended September 30, 2001 and 2000...............................5

Notes to Consolidated Financial Statements................6, 7, 8, 9, 10 and 11

Item 2. Management's Discussion and Analysis of Financial Condition
and Results of Operations....................................12, 13 and 14

PART II. OTHER INFORMATION AND SIGNATURE ............................15 and 16

Page 2 of 16
Part I. Financial Information
-----------------------------
Universal Health Realty Income Trust
------------------------------------
Condensed Consolidated Statements of Income
-------------------------------------------
(amounts in thousands, except per share amounts)
(unaudited)

<TABLE>
<CAPTION>
Three Months Nine Months
Ended September 30, Ended September 30,
--------------------- ---------------------
2001 2000 2001 2000
--------- -------- --------- --------
<S> <C> <C> <C> <C>
Revenues (Note 2):
- ------------------

Base rental - UHS facilities $ 3,253 $ 3,520 $ 9,759 $ 10,561
Base rental - Non-related parties 2,744 2,656 8,303 7,481
Bonus rental - UHS facilities 893 725 2,572 2,272
--------- -------- --------- --------
6,890 6,901 20,634 20,314
--------- -------- --------- --------

Expenses:
- ---------

Depreciation & amortization 1,101 1,125 3,291 3,316
Interest expense 616 1,600 3,234 4,519
Advisory fees to UHS 334 341 1,001 1,005
Other operating expenses 759 688 2,327 2,082
--------- -------- --------- --------
2,810 3,754 9,853 10,922
--------- -------- --------- --------

Income before equity in limited liability companies 4,080 3,147 10,781 9,392

Equity in income of limited liability companies 868 719 2,567 2,190

Loss on derivatives (71) -- (28) --
--------- -------- --------- --------
Net Income $ 4,877 $ 3,866 $ 13,320 $ 11,582
========= ======== ========= ========


Net Income per share - basic $ 0.42 $ 0.43 $ 1.32 $ 1.29
========= ======== ========= ========

Net Income per share - diluted $ 0.42 $ 0.43 $ 1.31 $ 1.29
========= ======== ========= ========

Weighted average number of shares outstanding - basic 11,622 8,979 10,097 8,981
Weighted average number of share equivalents 57 29 49 20
--------- -------- --------- --------
Weighted average number of shares and equivalents outstanding - diluted 11,679 9,008 10,146 9,001
========= ======== ========= ========
</TABLE>

The accompanying notes are an integral part of these financial statements.

Page 3 of 16
Universal Health Realty Income Trust
------------------------------------
Consolidated Balance Sheets
---------------------------
(amounts in thousands, except share data)
(unaudited)

<TABLE>
<CAPTION>
September 30, December 31,
Assets: 2001 2000
- ------- ------------- ------------
<S> <C> <C>
Real Estate Investments:
Buildings & improvements $ 159,680 $ 159,243
Accumulated depreciation (42,336) (39,080)
------------- ------------
117,344 120,163
Land 22,929 22,929
Construction in progress 40 16
------------- ------------
Net Real Estate Investments 140,313 143,108
------------- ------------

Investments in limited liability companies ("LLCs") 44,206 39,164

Other Assets:
Cash 529 294
Bonus rent receivable from UHS 898 796
Rent receivable from non-related parties 56 208
Deferred charges and other assets, net 91 88
------------- ------------
$ 186,093 $ 183,658
============= ============

Liabilities and Shareholders' Equity:
- -------------------------------------

Liabilities:
Bank borrowings $ 30,507 $ 80,672
Note payable to UHS 1,427 1,359
Accrued interest 309 392
Accrued expenses & other liabilities 4,026 1,459
Tenant reserves, escrows, deposits and prepaid rents 468 459

Minority interest 47 60

Shareholders' Equity:
Preferred shares of beneficial interest,
$.01 par value; 5,000,000 shares authorized;
none outstanding -- --
Common shares, $.01 par value;
95,000,000 shares authorized; issued
and outstanding: 2001 - 11,622,356
2000 - 8,980,064 116 90
Capital in excess of par value 183,293 129,110
Accumulated other comprehensive income:
Cash flow hedges (2,439) --
Cumulative net income 170,006 156,686
Cumulative dividends (201,667) (186,629)
------------- ------------
Total Shareholders' Equity 149,309 99,257
------------- ------------
$ 186,093 $ 183,658
============= ============
</TABLE>

The accompanying notes are an integral part of these financial statements.

Page 4 of 16
Universal Health Realty Income Trust
------------------------------------
Consolidated Statements of Cash Flows
-------------------------------------
(amounts in thousands, unaudited)

<TABLE>
<CAPTION>
Nine months ended September 30,
------------------------------------
2001 2000
-------- --------
<S> <C> <C>
Cash flows from operating activities:
Net income $ 13,320 $ 11,582
Adjustments to reconcile net income to net cash
provided by operating activities:
Depreciation & amortization 3,291 3,316
Loss on derivatives 28 --
Changes in assets and liabilities:
Rent receivable 50 (135)
Accrued expenses & other liabilities 181 218
Tenant escrows, deposits & deferred rents 9 (35)
Accrued interest (83) 328
Deferred charges & other (29) (341)
-------- --------
Net cash provided by operating activities 16,767 14,933
-------- --------

Cash flows from investing activities:
Investments in limited liability companies ("LLCs") (5,949) (4,174)
Advances made to a LLC, net of repayments (175) --
Acquisitions and additions to land, buildings and CIP (462) (9,320)
Cash distributions in excess of income from LLCs 1,081 913
-------- --------
Net cash used in investing activities (5,505) (12,581)
-------- --------

Cash flows from financing activities:
Additional borrowings -- 9,665
Repayments of long-term debt (50,165) (49)
Dividends paid (15,038) (12,353)
Repurchase of shares of beneficial interest -- (181)
Issuance of shares of beneficial interest 54,176 23
-------- --------
Net cash used in financing activities (11,027) (2,895)
-------- --------

Increase (decrease) in cash 235 (543)
Cash, beginning of period 294 852
-------- --------
Cash, end of period $ 529 $ 309
======== ========

Supplemental disclosures of cash flow information:
Interest paid $ 3,249 $ 4,133
======== ========
</TABLE>


See accompanying notes to these condensed financial statements.

Page 5 of 16
UNIVERSAL HEALTH REALTY INCOME TRUST
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
SEPTEMBER 30, 2001
(unaudited)

(1) General

The financial statements included herein have been prepared by the Trust,
without audit, pursuant to the rules and regulations of the Securities and
Exchange Commission and reflect all adjustments which, in the opinion of the
Trust, are necessary to fairly present results for the interim periods. Certain
information and footnote disclosures normally included in financial statements
prepared in accordance with generally accepted accounting principles have been
condensed or omitted pursuant to such rules and regulations, although the Trust
believes that the accompanying disclosures are adequate to make the information
presented not misleading. It is suggested that these financial statements be
read in conjunction with the financial statements, accounting policies and the
notes thereto included in the Trust's Annual Report on Form 10-K for the year
ended December 31, 2000.

In this Quarterly Report on Form 10-Q, the term "revenues" does not include the
revenues of the unconsolidated limited liability companies in which the Trust
has various non-controlling equity interests ranging from 33% to 99%. The Trust
accounts for its share of the income/loss from these investments by the equity
method.

(2) Relationship with Universal Health Services, Inc.

Approximately 60% and 62% for the three month periods ended September 30, 2001
and 2000, respectively, and 60% and 63% for the nine month periods ended
September 30, 2001 and 2000, respectively, of the Trust's consolidated revenues
were earned under the terms of the leases with wholly-owned subsidiaries of
Universal Health Services, Inc. ("UHS"). UHS has unconditionally guaranteed the
obligations of its subsidiaries under the leases. Below is the detailed listing
of the revenues received from UHS and other non-related parties for the three
and nine months ended September 30, 2001 and 2000:

<TABLE>
<CAPTION>
Three Months Ended Nine Months Ended
September 30, September 30,
------------- -------------
(in thousands)
<S> <C> <C> <C> <C>
2001 2000 2001 2000
------ ------ ------- -------
Base rental - UHS facilities $3,253 $3,520 $ 9,759 $10,561
Base rental - Non-related parties 2,744 2,656 8,303 7,481
------ ------ ------- -------
Total base rental 5,997 6,176 18,062 18,042
------ ------ ------- -------

Bonus rental - UHS facilities 893 725 2,572 2,272
------ ------ ------- -------
Total bonus rental 893 725 2,572 2,272
------ ------ ------- -------
Total revenues $6,890 $6,901 $20,634 $20,314
====== ====== ======= =======
</TABLE>

The decrease in base rentals from UHS facilities for the three and nine month
periods ended September 30, 2001 as compared to the comparable prior year
periods resulted from the purchase of previously leased property from the Trust
by Meridell Achievement Center, Inc., (a subsidiary of UHS) in December, 2000.

Page 6 of 16
Pursuant to the terms of its leases with subsidiaries of UHS, the Trust earns
fixed monthly base rents plus additional rents based on a percentage of the
facility's net patient revenue in excess of a base amount. The additional
rents, which are paid quarterly, are calculated using each facility's actual
monthly net patient revenues.

UHS owned approximately 6.6% percent of the Trust's outstanding shares of
beneficial interest as of September 30, 2001. The Trust has granted UHS an
option to purchase Trust shares in the future at fair market value to enable UHS
to maintain a 5% interest in the Trust.

UHS of Delaware, Inc. (the "Advisor"), serves as Advisor to the Trust under an
Advisory Agreement dated December 24, 1986 between the Advisor and the Trust
(the "Advisory Agreement"). The Advisory Agreement expires on December 31 of
each year, however, it is renewable by the Trust, subject to a determination by
the Trustees who are unaffiliated with UHS, that the Advisor's performance has
been satisfactory. The Advisory Agreement may be terminated for any reason upon
sixty days written notice by the Trust or the Advisor. The Advisory Agreement
has been renewed for 2001. The Advisory Agreement provides that the Advisor is
entitled to receive an annual advisory fee equal to .60% of the average invested
real estate assets of the Trust, as derived from its consolidated balance sheet
from time to time. The Advisory fee is payable quarterly, subject to adjustment
at year end based upon audited financial statements of the Trust. The Trust has
no salaried employees and the Trust's officers are all employees of UHS of
Delaware, Inc., a wholly-owned subsidiary of UHS. In 2001, the Trustees awarded
a $50,000 bonus to the President, Chief Financial Officer, Secretary and Trustee
of the Trust and UHS of Delaware, Inc. agreed to a $50,000 reduction in the
annual advisory fee paid by the Trust. Advisory fees paid to UHS amounted to
$334,000 and $341,000 for the three months ended September 30, 2001 and 2000,
respectively, and $1,001,000 and $1,005,000 for the nine month periods ended
September 30, 2001 and 2000, respectively.

(3) Dividends

A dividend of $.47 per share or $5.5 million in the aggregate was declared by
the Board of Trustees on September 4, 2001 and was paid on September 28, 2001 to
shareholders of record as of September 14, 2001.

(4) Accounting for Derivative Instruments and Hedging Activities

Effective January 1, 2001, the Trust adopted Statement of Financial Accounting
Standards ("SFAS") No. 133, "Accounting for Derivative Instruments and Hedging
Activities", and its corresponding amendments under SFAS No. 138. SFAS No. 133
requires the Trust to measure every derivative instrument (including certain
derivative instruments embedded in other contracts) at fair value and record
them in the balance sheet as either an asset or liability. Changes in the fair
value of derivatives are recorded currently in earnings unless special hedge
accounting criteria are met. For derivatives designated as fair value hedges,
the changes in fair value of both the derivative instrument and the hedged item
are recorded in earnings. For derivatives designated as cash flow hedges, the
effective portions of changes in the fair value of the derivative are reported
in other comprehensive income ("OCI"). The ineffective portions of hedges are
recognized in earnings in the current period.

Page 7 of 16
The adoption of this new standard as of January 1, 2001 resulted in a loss
recorded as a cumulative effect of an accounting change of approximately
$532,000 in other comprehensive income to recognize at fair value all
derivatives that are designated as cash flow hedging instruments. As of the
date of adoption and through the period ended September 30, 2001, the Trust was
not party to any derivative contracts designated as fair value hedges. The
Trust recorded an additional loss of $1,151,000 and $1,907,000, respectively, in
other comprehensive income to recognize the change in value during the three and
nine month periods ended September 30, 2001. The gains and losses are
reclassified into earnings as the underlying hedged item affects earnings, such
as when the forecast interest payment occurs. It is expected that $756,000 of
net losses in accumulated other comprehensive income will be reclassified into
earnings within the next twelve months. The Trust also recorded an unfavorable
$71,000 in current earnings for the three months ended September 30, 2001 and a
favorable $13,000 in current earnings for the nine months ended September 30,
2001 to recognize the ineffective portion of the cash flow hedging instruments.
As of September 30, 2001, the maximum length of time over which the Trust is
hedging its exposure to the variability in future cash flows for forecasted
transactions is through November, 2006. In June 2001, the Trust reclassified a
loss of $41,000 from accumulated other comprehensive income into earnings as a
result of the discontinuance of a cash flow hedge due to the probability of the
original forecasted transaction not occurring.

The Trust formally assesses, both at inception of the hedge and on an ongoing
basis, whether each derivative is highly effective in offsetting changes in fair
values or cash flows of the hedged item. If it is determined that a derivative
is not highly effective as a hedge or if a derivative ceases to be a highly
effective hedge, the Trust will discontinue hedge accounting prospectively.

The Trust manages its ratio of fixed to floating rate debt with the objective of
achieving a mix that management believes is appropriate. To manage this mix in a
cost-effective manner, the Trust, from time to time, enters into interest rate
swap agreements, in which it agrees to exchange various combinations of fixed
and/or variable interest rates based on agreed upon notional amounts.

Page 8 of 16
(5) Comprehensive Income (Loss)

Comprehensive income (loss) represents net income (loss) plus the results of
certain non-shareowners' equity changes not reflected in the Consolidated
Statements of Income. The components of comprehensive income (loss) are as
follows:

<TABLE>
<CAPTION>
Three Months Ended Nine Months Ended
------------------ -----------------
September 30, September 30,
------------- -------------
2001 2000 2001 2000
---- ---- ---- ----
<S> <C> <C> <C> <C>
Net income $ 4,877 $3,866 $13,320 $11,582

Other comprehensive income (loss):
Cumulative effect of change in accounting
principle (SFAS 133) on other
comprehensive income ---- --- (532) ---
Unrealized derivative gains/(losses) on cash
flow hedges (1,151) --- (1,907) ---
-------- ------- -------- --------
Comprehensive income $ 3,726 $3,866 $10,881 $11,582
======== ======= ======== ========
</TABLE>


(6) Acquisitions

During the third quarter, the Trust invested $2.8 million in exchange for a 79%
non-controlling interest in a limited liability company that owns and operates
the Papago Medical Park, a 79,637 square foot medical office building located in
Phoenix, Arizona.

Also during the third quarter, the Trust invested $45,000, and committed to
invest a total of $3.4 million, in exchange for an 80% non-controlling interest
in a limited liability company that will construct and own the Deer Valley
Medical Office II located in Phoenix, Arizona.

Page 9 of 16
(7) Summarized Financial Information of Equity Affiliates

The following table represents summarized financial information of the limited
liability companies ("LLCs") accounted for by the equity method. Amounts
presented include investments in the following LLCs as of September 30, 2001:

Name of LLC Property Owned by LLC
----------------------- ----------------------

DSMB Properties Desert Samaritan Hospital MOBs
DVMC Properties Desert Valley Medical Center MOBs
Parkvale Properties Maryvale Samaritan Hospital MOBs
Suburban Properties Suburban Medical Center MOBs
Litchvan Investments Samaritan West Valley Medical Center
Paseo Medical Properties II Thunderbird Paseo Medical Plaza and
Thunderbird Paseo Medical Plaza II (a.)
Willetta Medical Properties Edwards Medical Plaza
DesMed Desert Springs Medical Plaza
PacPal Investments Pacifica Palms Medical Plaza
RioMed Investments Rio Rancho Medical Center
West Highland Holdings St. Jude Heritage Health Complex
Santa Fe Scottsdale Santa Fe Professional Plaza
Bayway Properties East Mesa Medical Center
653 Town Center Drive Summerlin Hospital Medical Office Building
575 Hardy Investors Centinela Medical Building Complex
653 Town Center Phase II Summerlin Hospital Medical Office Building II
23560 Madison Skypark Professional Medical Building
Brunswick Associates (b.) Mid Coast Hospital Medical Office Building
Papago Medical Properties Papago Medical Office Building
Deerval Properties (c.) Deer Valley Medical Office II

(a.) As of September 30, 2001, the Trust has invested $568,000 in the
Thunderbird Paseo Medical Plaza II project which was completed and opened
during the third quarter. The Trust has committed to invest a total of $1.9
million in exchange for a 75% non-controlling interest in a LLC that owns a
medical office building in Glendale, Arizona.

(b.) As of September 30, 2001, the Trust has not yet invested any funds in this
project, however, the Trust has committed to invest $1.9 million in
exchange for a 74% non-controlling interest in a LLC that will construct
and own a medical office building in Brunswick, Maine, scheduled to be
completed and opened during the fourth quarter.

(c.) As of September 30, 2001, the Trust has invested $45,000 in the Deer Valley
Medical Office II project. The Trust has committed to invest a total of
$3.4 million in exchange for an 80% non-controlling interest in a LLC that
will construct and own a medical office building in Phoenix, Arizona,
scheduled to be completed and opened during the second quarter of 2002.

<TABLE>
<CAPTION>
Three Months Nine Months
Ended September 30, Ended September 30,
----------------------------------------------------
2001 2000 2001 2000
----------------------------------------------------
(amounts in thousands)
<S> <C> <C> <C> <C>
Revenues $8,404 $5,582 $19,384 $15,995
Expenses 7,499 4,787 16,492 13,493
Net Income 905 795 2,892 2,502
UHT's share of net income 868 719 2,567 2,190
</TABLE>

Page 10 of 16
As of September 30, 2001, these LLCs had approximately $97.1 million of debt,
which is non-recourse to the Trust, payable to third-party lending institutions.

(8) Other Matters

As previously reported, in July 2001 the Trust received comments from the staff
of the SEC related to the Trust's method of recording additional rents.
Subsequent to the third quarter of 2001, this matter was resolved and there will
be no change to the Trust's previously reported financial statements.

Page 11 of 16
Item 2.    Management's Discussion and Analysis of Financial Condition
and Results of Operations

Forward-Looking Statements
- --------------------------

The matters discussed in this report, as well as the news releases issued from
time to time by the Trust, include certain statements containing the words
"believes", "anticipates", "intends", "expects", and words of similar import,
which constitute "forward-looking statements" within the meaning of Private
Securities Litigation Reform Act of 1995. Such forward-looking statements
involve known and unknown risks, uncertainties and other factors that may cause
the actual results, performance or achievements of the Trust's or industry
results to be materially different from any future results, performance or
achievements expressed or implied by such forward-looking statements. Such
factors include, among other things, the following: a substantial portion of the
Trust's revenues are dependent on one operator, Universal Health Services, Inc.,
("UHS"); a substantial portion of the Trust's leases are involved in the
healthcare industry which is undergoing substantial changes and is subject to
possible changes in the levels and terms of reimbursement from third-party
payors and government reimbursement programs, including Medicare and Medicaid;
the Trust's ability to finance its growth on favorable terms; liability and
other claims asserted against the Trust or operators of the Trust's facilities,
and other factors referenced herein. Additionally, the operators of the Trust's
facilities, including UHS, are confronted with other issues such as: industry
capacity; demographic changes; existing laws and government regulations and
changes in or failure to comply with laws and governmental regulations; the
ability to enter into managed care provider agreements on acceptable terms;
competition; the loss of significant customers; technological and pharmaceutical
improvements that increase the cost of providing, or reduce the demand for
healthcare; and the ability to attract and retain qualified personnel, including
physicians. Management of the Trust is unable to predict the effect, if any,
these factors will have on the operating results of its lessees, including the
facilities leased to subsidiaries of UHS. Given these uncertainties, prospective
investors are cautioned not to place undue reliance on such forward-looking
statements. The Trust disclaims any obligation to update any such factors or to
publicly announce the result of any revisions to any of the forward-looking
statements contained herein to reflect future events or developments.

Results of Operations
- ---------------------

The Trust has investments in forty-two facilities located in fifteen states.
The Trust invests in healthcare and human service related facilities including
acute care hospitals, behavioral healthcare facilities, rehabilitation
hospitals, sub-acute care facilities, surgery centers, child-care centers and
medical office buildings.

The third quarter dividend of $.47 per share or $5.5 million in the aggregate
was paid on September 28, 2001.

For the quarters ended September 30, 2001 and 2000, net income totaled
$4,877,000 and $3,866,000 or $.42 and $.43 per share (basic and diluted), on net
revenues of $6,890,000 and $6,901,000, respectively. For the nine months ended
September 30, 2001 and 2000, net income totaled $13,320,000 and $11,582,000 or
$1.31 and $1.29 per diluted share on net revenues of $20,634,000 and
$20,314,000, respectively.

Page 12 of 16
The $11,000 decrease in net revenues during the three month period ended
September 30, 2001 as compared to the comparable prior year quarter was due
primarily to a $267,000 decrease in base rental from UHS facilities, partially
offset by an $88,000 increase in base rental from non-related parties and a
$168,000 increase in bonus rental from UHS facilities. The $320,000 increase in
net revenues during the nine month period ended September 30, 2001 as compared
to the comparable prior year period was due primarily to a $822,000 increase in
base rental from non-related parties and a $300,000 increase in bonus rental
from UHS facilities partially offset by a $802,000 decrease in base rental from
UHS facilities.

The increases in base rentals from non-related parties resulted primarily from
the revenues generated from the Southern Crescent II medical office building
which was opened during the third quarter of 2000. The decreases in base rentals
from UHS facilities resulted from the purchase of previously leased property
from the Trust by Meridell Achievement Center, Inc., (a subsidiary of UHS) in
December, 2000.

Other operating expenses increased $71,000 or 10% during the third quarter of
2001 and increased $245,000 or 12% during the 2001 nine month period as compared
to the comparable prior year periods. Included in the Trust's other operating
expenses were the expenses related to the medical office buildings in which the
Trust has a controlling ownership interest which totaled $585,000 and $511,000
for the three month periods ended September 30, 2001 and 2000, respectively, and
$1,767,000 and $1,549,000 for the nine month periods ended September 30, 2001
and 2000, respectively. A portion of the expenses associated with the medical
office buildings are passed on directly to the tenants and are included as
revenues in the Trust's statements of income.

Included in the Trust's financial results was $868,000 and $719,000 for the
three months ended September 30, 2001 and 2000, respectively, and $2,567,000 and
$2,190,000 for the nine months ended September 30, 2001 and 2000, respectively,
of income generated from the Trust's ownership in limited liability companies
which own medical office buildings in Arizona, California, Kentucky, New Mexico
and Nevada.

The Trust adopted SFAS No. 133 effective January 1, 2001. The adoption of this
new standard for the three and nine months ended September 30, 2001 resulted in
losses on derivatives of $71,000 and $28,000, respectively.

Funds from operations ("FFO"), which is the sum of net income plus depreciation
expense for consolidated investments and unconsolidated investments plus or
minus gains/losses on derivatives, increased 19% to $6.9 million for the three
months ended September 30, 2001, and increased 13% to $19.1 million for the
nine months ended September 30, 2001. Contributing to the increases in FFO
during the three and nine month periods ended September 30, 2001, as compared to
the comparable prior year periods, was a reduction in interest expense of
$984,000 and $1,285,000 for the three and nine month periods ended September 30,
2001, respectively, as compared to the comparable prior year periods. The
reduction in interest expense resulted primarily from the $53.9 million
repayment of outstanding borrowings under the revolving credit agreement using
the net proceeds generated for the issuance of an additional 2.6 million shares
of beneficial interest in June, 2001. FFO may not be calculated in the same
manner for all companies, and accordingly, FFO as presented above may not be
comparable to similarly titled measures by other companies. FFO does not
represent cash flows from operations as defined by generally accepted accounting
principles and should not be considered as an alternative to net income as an
indicator of the Trust's operating performance or to cash flows as a measure of
liquidity.

Page 13 of 16
Liquidity and Capital Resources
- -------------------------------

Net cash provided by operating activities was $16.8 million for the nine months
ended September 30, 2001 and $14.9 million for the nine months ended September
30, 2000. The $1.9 million net favorable change during the first nine months
of 2001 as compared to the comparable prior year period was primarily
attributable to a $1.7 million favorable change in net income plus the addback
of the non-cash charges (depreciation and amortization and loss on derivatives).

During the first nine months of 2001, the $17.9 million of cash generated from
operating activities, (includes $1.1 million of cash distributions in excess of
income received from the various LLCs in which the Trust owns a non-controlling
interest) and the $53.9 million of net proceeds generated from the issuance of
2.6 million shares of beneficial interest were used primarily to: (i) repay debt
($50.2 million); (ii) invest in LLCs in which the Trust owns various non-
controlling interests ($6.1 million), and; (iii) pay dividends ($15.0 million).

During the first nine months of 2000, the $15.8 million of cash generated from
operating activities, (includes $900,000 of cash distributions in excess of
income received from the various LLCs in which the Trust owns a non-controlling
interest) and the $9.6 million of additional borrowings were used primarily to:
(i) purchase a medical office building located in Danbury, Connecticut ($6.4
million); (ii) purchase a 95% equity interest in a limited liability company
that owns and operates Skypark Professional Medical Building located in
Torrance, California ($1.8 million); (iii) purchase a 98% equity interest in a
limited liability company that owns and operates the Centinella Medical Building
Complex located in Inglewood, California ($2.0 million); (iv) finance
construction of the Southern Crescent II Medical Office Building, which was
completed and opened during the third quarter of 2000, and capital expenditures
($2.8 million), and; (iv) pay dividends ($12.4 million).

In June of 2001, the Trust issued 2.6 million shares of beneficial interest at a
price of $21.57 per share. The shares were offered under the Trust's previously
filed $100 million shelf registration statement. The equity issuance generated
net proceeds of $53.9 million which were used to repay outstanding borrowings
under the Trust's $100 million revolving credit facility. Pursuant to the terms
of the Trust's original revolving credit agreement, the $100 million commitment
was to be reduced by 50% of the net proceeds generated from the issuance of
equity. During the second quarter of 2001, the revolving credit agreement was
amended to waive the commitment reduction provision, thereby keeping the
commitment at $100 million.

As of September 30, 2001, the Trust had approximately $64.9 million of unused
borrowing capacity under the terms of its $100 million revolving credit
agreement. The agreement expires on June 24, 2003, at which time all amounts
then outstanding are required to be repaid. Additional funds may be obtained
either through refinancing the existing revolving credit agreement and/or the
issuance of long-term securities.

Page 14 of 16
PART II. OTHER INFORMATION
UNIVERSAL HEALTH REALTY INCOME TRUST

Item 3. Quantitative and Qualitative Disclosures About Market Risk
- ------------------------------------------------------------------

There have been no material changes in the quantitative and qualitative
disclosures in 2001. Reference is made to Item 7 in the Annual Report on Form
10-K for the year ended December 31, 2000.


Item 6. Exhibits and Reports on Form 8-K
- -----------------------------------------

(a) Exhibits:

None

(b) Reports on form 8-K:

None

All other items of this report are inapplicable.

Page 15 of 16
Signatures

Pursuant to the requirements of the Securities Exchange Act of 1934, the
Registrant has duly caused this report to be signed on its behalf by the
undersigned thereunto duly authorized.


Date: November 12, 2001 UNIVERSAL HEALTH REALTY INCOME TRUST
(Registrant)



/s/ Kirk E. Gorman
---------------------------------------
Kirk E. Gorman, President,
Chief Financial Officer, Secretary and
Trustee

(Principal Financial Officer and Duly
Authorized Officer.)

Page 16 of 16